1h Free Analyst Time
The cell therapy technologies market is forecasted to grow by USD 5.92 billion during 2023-2028, accelerating at a CAGR of 19.7% during the forecast period. The report on the cell therapy technologies market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increased investment in cell therapy, launch of cell and gene therapy facilities, and rising traction of car t-cell therapies.
The cell therapy technologies market is segmented as below:
By Technology
- Somatic cell technologies
- Gene modification techniques
- Genome editing technologies
- Others
By End-user
- Biopharmaceuticals and biotechnology companies
- CROs and CMOs
- Research institute and cell banks
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the cell therapy technologies market covers the following areas:
- Cell Therapy Technologies Market sizing
- Cell Therapy Technologies Market forecast
- Cell Therapy Technologies Market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Technology
9 Market Segmentation by End-user
10 Customer Landscape
11 Geographic Landscape
12 Drivers, Challenges, and Opportunity/Restraints
13 Competitive Landscape
14 Competitive Analysis
15 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global cell therapy technologies market: Avantor Inc., Becton Dickinson and Co., Bio Techne Corp., Corning Inc., Danaher Corp., Fresenius Kabi AG, FUJIFILM Irvine Scientific Inc., Korber Medipak Systems GmbH, Lonza Group Ltd., Merck KGaA, Miltenyi Biotec B.V. and Co. KG, Revvity Inc., Sartorius AG, STEMCELL Technologies Inc., TERUMO BCT, INC, and Thermo Fisher Scientific Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is mergers and acquisitions."
According to the report, one of the major drivers for this market is the increased investment in cell therapy.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Avantor Inc.
- Becton Dickinson and Co.
- Bio Techne Corp.
- Corning Inc.
- Danaher Corp.
- Fresenius Kabi AG
- FUJIFILM Irvine Scientific Inc.
- Korber Medipak Systems GmbH
- Lonza Group Ltd.
- Merck KGaA
- Miltenyi Biotec B.V. and Co. KG
- Revvity Inc.
- Sartorius AG
- STEMCELL Technologies Inc.
- TERUMO BCT INC
- Thermo Fisher Scientific Inc.
